Results 191 to 200 of about 1,155,035 (254)

Comparative Prognostic Value of the Triglyceride‐Glucose Index, hs‐CRP, and the Derived C‐Reactive Protein–Triglyceride‐Glucose Index for Major Adverse Cardiovascular and Cerebrovascular Events in Acute Coronary Syndrome: Insights From a Prospective Cohort

open access: yesMedComm, Volume 7, Issue 11, November 2026.
The TyG index, hs‐CRP, and CTI were associated with long‐term MACCE risk in ACS patients, with CTI showing numerically higher predictive performance. Higher CTI indicated increased MACCE risk. •Why did we undertake this study? To improve long‐term MACCE risk assessment in patients with ACS. •What specific question(s) do we wanted to answer?
Wenjie Wang   +10 more
wiley   +1 more source

Targeted and Biosafe Delivery of Spermidine to Ameliorate Foreign Body Responses After Synthetic Vascular Graft Implantation In Vivo

open access: yesSmall Structures, Volume 7, Issue 11, November 2026.
Platelet membrane fragment‐modified lipid nanoparticles (PLNP‐SPD) safely deliver spermidine, reduce its cytotoxicity, selectively bind inflamed macrophages, and suppress their inflammatory activation. After adventitial delivery around vascular grafts, PLNP‐SPD reduces foreign body reactions and inflammation, promotes implanted vessel regeneration in ...
Jiahui Wu   +6 more
wiley   +1 more source

Risk Factors for Myocardial Injury During Cardio‐Pulmonary Bypass‐Assisted Heart Surgery: A Retrospective Single‐Center Study

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 10, November 2026.
ABSTRACT Introduction Myocardial injury is a significant contributor to 30‐day mortality after cardiac surgery with cardiopulmonary bypass. We aimed to investigate the association between mean arterial pressure, norepinephrine use during the aorta cross‐clamp period, and aorta cross‐clamp duration with myocardial injury during cardiopulmonary bypass ...
Julie T. Holm   +6 more
wiley   +1 more source

SURGELLA: A Scoping Review of Impella‐Assisted Hemodynamic Support in High‐Risk Non‐Cardiac Surgery

open access: yesArtificial Organs, Volume 50, Issue 11, Page 1532-1545, November 2026.
In selected patients with severe LV dysfunction, Impella‐supported non‐cardiac surgery may provide a temporary hemodynamic bridge to otherwise prohibitive procedures. Published evidence remains limited to a small number of highly selected cases, supporting technical feasibility rather than comparative benefit or generalizable safety.
Hussein Elghazaly   +6 more
wiley   +1 more source

Heart Donation After Controlled Circulatory Death in Noncardiac Surgery Hospitals With a Mobile Heart Team: A Case Series From an Italian Regional Program and Integrated Review of the Literature

open access: yesArtificial Organs, Volume 50, Issue 11, Page 1657-1667, November 2026.
In this series of 19 DCD donors using TA‐NRP, 89.5% of hearts were successfully transplanted with no PGD, no postoperative ECMO, and no 30‐day mortality, demonstrating the feasibility and safety of this approach. ABSTRACT Controlled donation after circulatory death (cDCD) with thoracoabdominal normothermic regional perfusion (TA‐NRP) has emerged ...
Maria Benedetto   +11 more
wiley   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1219-1233, November 2026.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala   +13 more
wiley   +1 more source

Clinical characteristics and in‐hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open‐loop era: A UK‐wide MINAP registry analysis

open access: yesDiabetic Medicine, Volume 43, Issue 11, November 2026.
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh   +6 more
wiley   +1 more source

Surgical Site Infection: Conditional Influence of Surgery Duration and ASA Classification in Major Procedures

open access: yesInternational Wound Journal, Volume 23, Issue 11, November 2026.
ABSTRACT Surgical site infection (SSI) is a major complication in surgical patients. This study aimed to investigate predictors of SSI in cardiac, neurological and orthopaedic surgeries. A total of 28,803 procedures (2015–2021) were analysed. Predictive variables included age, sex, ASA score, wound classification, operative duration and preoperative ...
Adriana Cristina Oliveira   +1 more
wiley   +1 more source

Clinical Outcomes After Catheter Ablation in Patients With Structural Heart Disease and Ventricular Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 11, Page 2651-2661, November 2026.
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto   +2 more
wiley   +1 more source

Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 11, Page 1986-1996, November 2026.
Among patients with type 2 diabetes undergoing percutaneous coronary intervention, thiazolidinedione use was independently associated with a significantly reduced risk of a composite of myocardial infarction, stroke, and all‐cause death, notably without an increased risk of admission for heart failure. ABSTRACT Background Thiazolidinediones (TZD) are a
Jinkwon Kim   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy